NCT01433809View on ClinicalTrials.gov

Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Cancer of the ThyroidNeoplasms, ThyroidThyroid AdenomaThyroid CancerThyroid Carcinoma
Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

All Listed Sponsors
lead

Norman Eberhardt

OTHER

NCT01433809 - Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm | Biotech Hunter | Biotech Hunter